» Articles » PMID: 37021642

Genetics of Familial Adult Myoclonus Epilepsy: From Linkage Studies to Noncoding Repeat Expansions

Overview
Journal Epilepsia
Specialty Neurology
Date 2023 Apr 6
PMID 37021642
Authors
Affiliations
Soon will be listed here.
Abstract

Familial adult myoclonus epilepsy (FAME) is a genetic epilepsy syndrome that for many years has resisted understanding of its underlying molecular cause. This review covers the history of FAME genetic studies worldwide, starting with linkage and culminating in the discovery of noncoding TTTTA and inserted TTTCA pentanucleotide repeat expansions within six different genes to date (SAMD12, STARD7, MARCHF6, YEATS2, TNRC6A, and RAPGEF2). FAME occurs worldwide; however, repeat expansions in particular genes have regional geographical distributions. FAME repeat expansions are dynamic in nature, changing in length and structure within germline and somatic tissues. This variation poses challenges for molecular diagnosis such that molecular methods used to identify FAME repeat expansions typically require a trade-off between cost and efficiency. A rigorous evaluation of the sensitivity and specificity of each molecular approach remains to be performed. The origin of FAME repeat expansions and the genetic and environmental factors that modulate repeat variability are not well defined. Longer repeats and particular arrangements of the TTTTA and TTTCA motifs within an expansion are correlated with earlier onset and increased severity of disease. Other factors such as maternal or paternal inheritance, parental age, and repeat length alone have been suggested to influence repeat variation; however, further research is required to confirm this. The history of FAME genetics to the present is a chronicle of perseverance and predominantly collaborative efforts that yielded a successful outcome. The discovery of FAME repeats will spark progress toward a deeper understanding of the molecular pathogenesis of FAME, discovery of new loci, and development of cell and animal models.

Citing Articles

Clinical efficacy of low-dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2.

Coppola A, Cuccurullo C, Senerchia G, Rubino M, Veneziano L, Brancati F Epilepsia Open. 2024; 10(1):321-328.

PMID: 39533755 PMC: 11803264. DOI: 10.1002/epi4.13100.


Sequence composition changes in short tandem repeats: heterogeneity, detection, mechanisms and clinical implications.

Rajan-Babu I, Dolzhenko E, Eberle M, Friedman J Nat Rev Genet. 2024; 25(7):476-499.

PMID: 38467784 DOI: 10.1038/s41576-024-00696-z.


Myoclonus: Differential diagnosis and current management.

Riva A, DOnofrio G, Ferlazzo E, Pascarella A, Pasini E, Franceschetti S Epilepsia Open. 2024; 9(2):486-500.

PMID: 38334331 PMC: 10984309. DOI: 10.1002/epi4.12917.


Familial adult myoclonus epilepsy: a pragmatic approach.

Cherian A, Divya K, Krishnan A Acta Neurol Belg. 2023; 124(2):389-394.

PMID: 38114875 DOI: 10.1007/s13760-023-02432-6.


Toward the use of novel alternative methods in epilepsy modeling and drug discovery.

Miguel Sanz C, Martinez Navarro M, Caballero Diaz D, Sanchez-Elexpuru G, Di Donato V Front Neurol. 2023; 14:1213969.

PMID: 37719765 PMC: 10501616. DOI: 10.3389/fneur.2023.1213969.


References
1.
Pan S, Li X, Li L, Lin H, Wang D, Zhang X . Comprehensive genetic, clinical and electrophysiological studies of familial cortical myoclonic tremor with epilepsy 1 highlight the role of gene configurations. Seizure. 2021; 87:69-74. DOI: 10.1016/j.seizure.2021.02.026. View

2.
Depienne C, Magnin E, Bouteiller D, Stevanin G, Saint-Martin C, Vidailhet M . Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p. Neurology. 2010; 74(24):2000-3. DOI: 10.1212/WNL.0b013e3181e396a8. View

3.
Loureiro J, Castro A, Figueiredo A, Silveira I . Molecular Mechanisms in Pentanucleotide Repeat Diseases. Cells. 2022; 11(2). PMC: 8773600. DOI: 10.3390/cells11020205. View

4.
Guerrini R, Bonanni P, Patrignani A, Brown P, Parmeggiani L, Grosse P . Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2. Brain. 2001; 124(Pt 12):2459-75. DOI: 10.1093/brain/124.12.2459. View

5.
Madia F, Striano P, Di Bonaventura C, De Falco A, De Falco F, Manfredi M . Benign adult familial myoclonic epilepsy (BAFME): evidence of an extended founder haplotype on chromosome 2p11.1-q12.2 in five Italian families. Neurogenetics. 2008; 9(2):139-42. DOI: 10.1007/s10048-008-0118-4. View